Literature DB >> 21767135

In vivo effect of surfactant on inflammatory cytokines during endotoxin-induced lung injury in rodents.

Neha Mittal1, Sankar Nath Sanyal.   

Abstract

Lipopolysaccharide (LPS) is a known inducer of acute respiratory distress syndrome (ARDS) in humans and animals. In this study, ARDS was developed in rats by intratracheal instillation of LPS and the effect of two types of surfactant (natural vs. synthetic) was examined to determine their potential corrective roles in general, as well as to compare the two surfactants against one another in particular, in endotoxin-induced lung injury. Sprague-Dawley male rats were divided into four groups, i.e., rats given: buffer controls; 055:B5 E. coli LPS only; LPS and then porcine surfactant (P-SF); or, LPS and then synthetic surfactant (S-SF). In vivo administration of LPS led to an increase in expression of the cytokines tumor necrosis factor-α, interleukin (IL)-1β, IL-2, IL-4, interferon-γ, monocyte chemotactic protein-1, and macrophage inflammatory protein-1β in the lungs of rats. These effects were confirmed by immunofluorescence in lung tissue sections and/or by protein (Western immunoblot) and mRNA expression (reverse transcription polymerase chain reaction) analyses of tissue samples. Apart from IL-4, concentrations of each of these cytokines in bronchoalveolar lavage fluid recovered from the animals were significantly increased in the LPS-treated hosts. Instillation of either surfactant (70 h after the LPS) into the airways diminished the expression of each of the inducible-cytokines, with the porcine (natural) form seeming having the greater inhibitory effect. These data suggest that surfactant can play an important role in the treatment of endotoxin-induced lung injury and might possess robust anti-inflammatory effects. Further, it seems that both the natural and synthetic surfactants prevent inflammatory outcomes in the lungs by controlling cytokine(s) production by various inflammatory cells. Last, the studies here clearly indicated that in this aspect, natural surfactant appears to be more beneficial compared to synthetic surfactant.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767135     DOI: 10.3109/1547691X.2011.591294

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  5 in total

1.  MicroRNA-181b stimulates inflammation via the nuclear factor-κB signaling pathway in vitro.

Authors:  Yazhen Wang; Genxiang Mao; Yuandong Lv; Qingdong Huang; Guofu Wang
Journal:  Exp Ther Med       Date:  2015-08-24       Impact factor: 2.447

2.  Inhibition of endotoxin-induced airway epithelial cell injury by a novel family of pyrrol derivates.

Authors:  Nuria E Cabrera-Benítez; Eduardo Pérez-Roth; Ángela Ramos-Nuez; Ithaisa Sologuren; José M Padrón; Arthur S Slutsky; Jesús Villar
Journal:  Lab Invest       Date:  2016-03-21       Impact factor: 5.662

3.  Anti-inflammatory activity of a novel family of aryl ureas compounds in an endotoxin-induced airway epithelial cell injury model.

Authors:  Nuria E Cabrera-Benitez; Eduardo Pérez-Roth; Milena Casula; Angela Ramos-Nuez; Carla Ríos-Luci; Carlos Rodríguez-Gallego; Ithaisa Sologuren; Virginija Jakubkiene; Arthur S Slutsky; José M Padrón; Jesús Villar
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

4.  Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress.

Authors:  Mehmet Yalaz; Sema Tanriverdi; Özgün Uygur; Özge Altun Köroğlu; Elif Azarsiz; Guzide Aksu; Nilgün Kültürsay
Journal:  Front Pediatr       Date:  2022-03-18       Impact factor: 3.418

5.  Host responses to concurrent combined injuries in non-human primates.

Authors:  Matthew J Bradley; Diego A Vicente; Benjamin A Bograd; Erin M Sanders; Crystal L Leonhardt; Eric A Elster; Thomas A Davis
Journal:  J Inflamm (Lond)       Date:  2017-11-02       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.